📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
30
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
🔄 Reverse Split
55%
• 50-day avg $0.39 below $1 exchange minimum
📉 Score Deterioration
40%
• Score rose 23 points recently (worsening)
📜 Warrant Exercise
15%
• Warrant overhang: 11.6% of shares outstanding
💹 Market Data
Market Cap$7.38M
Shares Outstanding17.17M
Float13.43M
Cash$174.6K
Debt$294.0K
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 2.51M shares
#1
Armistice Capital, LLC
1.54M shares
#2
Vanguard Group Inc
489.5K shares
#3
Ikarian Capital, LLC
138.1K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest380.7K
Days to Cover1.0
% of Float2.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for MGRX
📊 MGRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MGRX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.